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Abstract
Background: Osteoporosis is a disease characterized by decreased bone strength, decreased bone mass, and
bone deterioration. Oxidative damage is an important contributor to functional changes in the development of
osteoporosis. Here we found that porcine placenta hydrolysates (PPHs) protect MC3T3-E1 osteoblastic cells against
hydrogen peroxide (H2O2)-induced oxidative damage.
Methods: In vitro cell viability was determined using trypan blue dye exclusion. ER stress and apoptosis were
evaluated using immunoblotting and a commercially available caspase kit. ALP, osteocalcin, Runx2, and osterix
expression levels were evaluated by RT-PCR using isolated RNA. ROS, NADPH oxidase, and SOD activity levels
were also measured.
Results: We investigated the mechanisms underlying PPH-mediated inhibition of H2O2-induced ER stress and
ROS production. PPHs also regulated osteoblast differentiation via the upregulation of alkaline phosphatase (ALP)
expression in MC3T3-E1 osteoblastic cells. Also, treatment with PPHs enhanced the transcription of osteocalcin,
Runx2, and osterix. These effects were all associated with the antioxidant actions of PPHs. Moreover, PPHs reversed
the decrease in SOD activity, decreased ROS release, and inhibited NADPH oxidase activity in H2O2-treated
MC3T3-E1 osteoblastic cells.
Conclusions: PPHs protect cells against H2O2-induced cell damage when ER stress is involved. In addition,
PPHs enhance osteoblast differentiation. This enhancement likely explains the regulatory effect of PPHs on bone
metabolism disturbances, i.e. PPHs control ER stress and the related ROS production in osteoblasts.
Keywords: Osteoporosis, Oxidative damage, Alkaline phosphatase, Apoptosis, ROS
Abbreviations: ALP, Alkaline Phosphatase; ER, Endoplasmic Reticulum; H2O2, Hydrogen Peroxide; PPHs,
Porcine Placenta Hydrolysates; ROS, Reactive Oxygen Species; Tg, Thapsigargin
Background
Osteoporosis is characterized by decreased bone strength,
decreased bone mass, and bone tissue deterioration. An
imbalance between bone resorption and bone formation is
the dominant mechanism causing osteoporosis [1, 2].
Since new bone formation primarily depends on osteo-
blasts, factors that disturb their bone-forming characte-
ristics can lead to bone formation defects or related
pathological conditions. Osteoblasts are secretory cells
with well-developed endoplasmic reticulum (ER) cristae,
in which many secretory proteins are folded and then
secreted. The balance of osteoblasts and osteoclastic cells
is carefully controlled to maintain bone and the related
endocrinology homeostasis [1, 3, 4]. ROS are one of the
key factors responsible for dysregulation of bone mainten-
ance, especially osteoblast physiology. Osteoblasts are
coated with high levels of secreted proteins. When these
cells do not work effectively, ROS affect the secretory
function of the osteoblasts, resulting in detrimental signal-
ing to osteoclasts. Furthermore, during severe pathologic
stress, osteoblasts undergo apoptosis. This also disturbs
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the balance between osteoblasts and osteoclasts and
ultimately leads to bone resorption and related disease
conditions [5].
The ER plays a major role in controlling protein fold-
ing and secretion in cells. Various acute and chronic
conditions, including protein misfolding and Ca2+ dis-
turbances, can alter ER function and lead to ER stress
[6–8]. Furthermore, ER stress has been reported to con-
tribute to several diseases, including many bone diseases
[9, 10]. Osteoblast apoptosis associated with ER stress is
one of the predominant mechanisms of osteoporosis
pathogenesis [11–14]. In stressed osteoblasts, endocrine
function, including the production of bone formation
hormones (e.g., osteopontin and osteocalcin), is impaired
[15, 16]. Under stress conditions, ROS (e.g. H2O2) have
been identified as key detrimental messengers. More-
over, ROS have also been associated with ER stress in
other pathological conditions [17–19]. Numerous
studies have evaluated the role of ROS and ER stress
in bone development [3, 20–22]. Therefore, the iden-
tification of interventions that can control ROS-associated
ER stress is important for preventing and treating bone
disease.
The placenta is an organ found exclusively in women
during pregnancy that supplies nutrients and oxygen to
the developing fetus. The nutritional substances and
vitamins therein can be extracted in the form of porcine
placenta hydrolysates (PPHs). PPHs contain beneficial
bioactive components that inhibit aging, sunburns, and
oxidation [23, 24]. PPHs have also been used for wound
healing in Korean folk medicine [25, 26] and have been
demonstrated to exert immunomodulatory effects [27,
28]. However, the effect of PPHs on bone formation
remains unclear. To determine the role of PPHs in
the endocrine system, it is important to determine
the effects of PPHs on osteoblasts, a representative
endocrine cell associated with stress conditions. The
aim of our study was to evaluate the effects of PPHs
on H2O2-induced oxidative damage and the related
ER stress in MC3T3-E1 osteoblastic cells. We found
that PPHs regulate oxidative ER stress and the associ-
ated activation of antioxidants, thus enhancing differen-




PPHs were purchased from Codebio Inc. (Cheonan,
Republic of Korea). Hydrogen peroxide and thapsigargin
were obtained from Sigma Chemical Company (St.
Louis, MO, USA). Caspase-3 and -12 activity kits were
obtained from BioVision (Mountain View, CA, USA).
All other reagents used were of analytical grade and
were generally obtained from Sigma.
Extraction and quantitation of PPHs using HPLC-DAD
PPHs were purchased from Codebio Inc. (Cheonan,
Republic of Korea). Placentas were thawed using a
defroster and then washed with saline at 16 °C to re-
move blood and cords. Placentas were hydrolyzed using
papain, bromelain, pronase, and Alcalase at 70 ± 0.1 °C
for 2 days (pH 4.5–6.0). Next, hydrolytic enzymes were
inactivated at 100 ± 0.1 °C for 30 min and the resultant
hydrolysates were filtered. The lipids were then removed
by mixing with calcium and phosphate salts and by filter-
ing the insoluble particulate matter. Finally, the hydroly-
sates were adjusted to pH 7.0 ± 0.2 using calcium and
phosphate salts. Hydrolysates were mixed with AccQ-
Fluor buffer and Acc-Fluor reagent (Waters Corporation,
Milford, MA, USA), after which the mixture was heated at
80 °C. An aliquot of the sample was filtered and injected
into an AccQ-Tag column (150 × 2.1 mm, 3 μm particle
size; Waters Corporation, Milford, MA, USA) in an HPLC
instrument for chromatographic separation. A gradient
mixture of AccQ-Tag Eluent (A) and acetonitrile (B) was
used as the mobile phase at a flow rate of 1 mL/min at
30 °C. The initial eluent was 100 % A, which linearly de-
creased to 67 % A over 33 min. The eluent was switched
to 100 % B for 3 min and then switched back to 100 % A
for 26 min. Amino acids were detected using a fluo-
rescence detector at excitation and emission wavelengths
of 250 and 395 nm, respectively.
Cell culture and viability analysis
The murine calvaria-derived MC3T3-E1 osteoblast-like
cell line (4 to 10 passages) was purchased from the
American Type Culture Collection (ATCC; Manassas,
VA, USA). Cells were seeded at 1 × 105 cells/mL and
maintained in minimum essential medium (α-MEM)
supplemented with 10 % fetal bovine serum (FBS) and
penicillin-streptomycin (Invitrogen). Cells were incu-
bated at 37 °C in a 95 % air/5 % CO2 atm. Cell viability
was detected using a trypan blue exclusion assay. Briefly,
MC3T3-E1 cells (5 × 104 cells/well) were incubated in
12-well plates overnight and treated for 24 h with drugs
in medium containing 10 % serum. Cells were washed
with sterile phosphate-buffered saline (PBS), treated with
0.25 % trypsin-EDTA (GIBCO BRL), and harvested.
Cells were diluted in 0.1 % trypan blue (GIBCO BRL)
and then counted under a light microscope.
Immunoblotting
For immunoblotting, MC3T3-E1 osteoblastic cells were
lysed with extraction buffer. Proteins in the resultant
lysates (40 μg) were resolved on a polyacrylamide gel
and transferred to a nitrocellulose membrane. The blots
were probed overnight at 4 °C with primary antibodies,
washed, and probed again with species-specific sec-
ondary antibodies coupled to horseradish peroxidase
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(GE Healthcare, Piscataway, NJ, USA). Chemilumines-
cence reagents (GE Healthcare) were used for detection.
Primary antibodies consisted of rabbit anti-GADD153/C/
EBP homologous protein (CHOP), rabbit-anti-PERK, rat
anti-GRP78, rabbit anti-ATF6α, mouse anti-eIF2α, mouse
anti-β-actin (Santa Cruz Biotechnologies, Inc., Santa Cruz,
CA, USA), rabbit anti-IRE1α, and rabbit anti-p-eIF2 (Cell
Signaling Technologies, Inc., Danvers, MA, USA).
Measurement of caspase-3 activity
To analyze caspase-3 activity, pellets were resuspended
in extraction buffer [25 mM HEPES (pH 7.4), 0.1 %
Triton X-l00, 10 % glycerol, 5 mM DTT] and spun by
centrifugation at 13,000 rpm at 4 °C for 30 min. Soluble
protein (40 μg) was mixed with 100 μM caspase-3-
specific substrate Ac-DEVD-AFC (Sigma-Aldrich) and
incubated at 37 °C. Caspase-3 activity was analyzed by
monitoring fluorogenic AFC release at 37 °C. Substrate
cleavage was monitored at 405 nm using a SPECTRAmax
340 microplate reader and analyzed using SOFTmax PRO
software (Molecular Devices, Sunnyvale, CA, USA).
Measurement of caspase-12 activity
To analyze caspase-12 activity, pellets were measured by
detecting free AFC cleavage by caspase-12-specific sub-
strates. These experiments were performed with a
caspase-12 Assay Kit (Biovision, San Francisco, CA,
USA). After the lysates were incubated with ATAD-AFC
for 2 h at 37 °C, the absorbance of each sample was ana-
lyzed at 505 nm.
Measurement of alkaline phosphatase activity
To analyze ALP activity, cells were treated with Krebs
(control), PPHs (100 μg/mL), H2O2 (400 μM), and in the
presence or absence of 100 μg/mL PPHs. After treat-
ment for 4 h, cells were lysed. The amount of ALP activ-
ity and the protein concentration were measured in each
supernatant using an ALP activity assay kit (Cell Biolabs,
San Diego, CA, USA).
RT-PCR
The mRNA levels of ALP, osteocalcin, Runx2, osterix,
and GAPDH were determined using a PrimeScript™ RT
reagent Kit (TaKaRa Bioscience, Kyoto, Japan). The se-
quences of the primers used for RT-PCR were as follows:
ALP, forward primer: 5′-CCATGGTAGATTACGCTC
ACA-3′, reverse primer: 5′-ATGGAGGATTCCAGATA
CAGG-3′; osteocalcin, forward primer: 5′-AGCTAT
CAGACCAGTATGGCT-3′, reverse primer: 5′-TTTTG
GAGCTGCTGTGACATC-3′; Runx2, forward primer:
5′-CTCAGTGATTTAGGGCGCATT-3′, reverse primer:
5′-AGGGGTAAGACTGGTCATAGG-3′; Osterix, for-
ward primer: 5′- CGGGTCAGGTACAGTG-3′, reverse
primer: 5′- ACCATGACGACAAGGG-3′; and GAPDH,
forward primer: 5′-ATCACCATCTTCCAGGAG-3′, re-
verse primer: 5′-ATGGACTGTGGTCATGAG-3′. Re-
verse transcription was performed by incubating the
reactions at 37 °C for 15 min and then at 85 °C for 5 s.
For polymerase chain reaction amplification, an initial
denaturation step was performed at 94 °C for 3 min,
followed by annealing at 55 °C for 20 s and elongation at
72 °C for 45 s. In total, 35 cycles were performed.
NADPH oxidase activity assay
Cells were seeded in six-well plates and cultured for
48 h. Next, the cells were treated with 100 μM H2O2 for
6 h in the presence or absence of 100 μg/mL PPHs.
NADPH oxidase activity was determined based on
superoxide-induced lucigenin photoemission as described
by Rao and Maddala et al. [29]. Enzymatic assays were
performed in a final volume of 0.2 ml containing 50 mM
phosphate buffer (pH 7.0), 1 mM EGTA, 150 mM sucrose,
0.5 mM lucigenin, 0.1 mM NADPH, and cell lysis solu-
tion. Enzymatic reactions were initiated by the addition of
lucigenin. Photoemission, expressed as relative light units,
was measured every minute for 10 min using a lumin-
ometer. Assays were performed in the dark at room
temperature with all appropriate controls.
Superoxide dismutase (SOD) activity assay
Cells were seeded in six-well plates and cultured for
48 h. The cells were then treated with 100 μM H2O2 for
6 h in the presence or absence of 100 μg/mL PPHs.
Next, cells were harvested and the level of SOD activity
was determined using a SOD assay kit (k335-100, Biovi-
sion) according to the manufacturer’s instructions.
DCFDA assay (ROS production)
The cellular ROS level was measured by following the
protocol described by Badham et al. [30]. Briefly, cells
were treated with 100 μM H2O2 at 37 °C in the presence
or absence of 100 μg/mL PPHs for 6 h. Next, cells were
incubated with 10 μM 2′, 7′-dichlorofluorescein diace-
tate (DCFDA) at 37 °C for an additional 30 min. The
fluorescence intensity of 2′,7′-dichlorofluorescein, a
product of the reaction between DCFDA and cellular
ROS, was analyzed using a fluorescence reader (Spectra-
Max 190, Molecular Devices, Sunnyvale, CA, USA). Data
were normalized to the H2O2 absorbance values.
Statistical analysis
Results are presented as means ± standard errors of
the mean (SEMs) for multiple wells tested in at least
three separate experiments. MicroCal Origin software
(Northampton, MA, USA) was used for statistical calcula-
tions. Differences were tested for significance using one-
way analysis of variance (ANOVA) with Duncan’s multiple
range test.
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Results
PPHs protect against H2O2-induced cell death in
MC3T3-E1 osteoblastic cells
We first determined if PPHs exert concentration-
dependent effects on cell viability. Treatment with PPHs
for 6 h at concentrations ranging from 25 to 100 μg/mL
did not have any significant effect on cell survival
(Fig. 1a). However, treatment of cells for 6 h with 100,
200, or 400 μM H2O2 markedly increased cell death in a
concentration-dependent manner (Fig. 1b). Interestingly,
treatment of cells with 400 μM H2O2 and 25, 50, or
100 μg/mL PPHs markedly affected cell survival in a
concentration- and time-dependent manner (Fig. 1c and
d). Moreover, treatment with 100 μg/mL PPHs for
30 min significantly protected cells against H2O2-in-
duced (400 μM) cell damage. These findings suggest that
PPHs significantly protect MC3T3-E1 osteoblastic cells.
PPHs protect against H2O2-induced apoptosis in MC3T3-E1
osteoblastic cells
To evaluate whether PPHs could protect against ER
stress in osteoblasts, cells were treated with 400 μM
H2O2 for 6 h or 0.1 μM Tg (thapsigargin, a Ca
2+-ATPase
inhibitor) for 24 h to induce ER stress. To investigate
the ER stress response, the levels of GRP78, CHOP, p-
PERK, p-eIF2α, p-IRE1-α, and ATF6α were analyzed by
immunoblotting. The levels of these proteins were all
significantly increased in cells treated with 400 μM
H2O2 or 0.1 μM Tg. However, treatment with PPHs
inhibited this upregulation of GRP78, CHOP p-PERK, p-
eIF2α, p-IRE1-α, and ATF6α (Fig. 2a and b). Moreover,
PPHs inhibited H2O2-induced cell injury. Apoptosis
levels were measured by flow cytometry and are ex-
pressed in units of mean fluorescence intensity. As
shown in Fig. 3a-b, PPHs protected osteoblasts against
H2O2-induced apoptosis. H2O2 treatment also induced
nuclear condensation and fragmentation, characteristics
of apoptosis. Pretreatment with PPHs markedly at-
tenuated these effects (Fig. 3a). Moreover, the apoptosis
level was 31.55 ± 1.02 % after H2O2 treatment for 6 h,
whereas the apoptosis level in the PPHs group was
15.33 ± 2.1 % (Fig. 3b). These results confirm the pro-
tective effects of PPHs against H2O2-induced apoptosis
in cells. Caspase-12 activation is associated with
a b
c d
Fig. 1 PPHs regulate H2O2-induced cell death in MC3T3-E1 osteoblastic cells. a To test the cell viability of PPHs in MC3T3-E1 cells, cells were treated
with 0, 25, 50, or 100 μg/mL PPHs only for 6 h. Cell viability was estimated via the trypan blue exclusion test. Untreated cells were used as the control.
b To test the cell viability of H2O2 in MC3T3-E1 cells, cells were treated with 0, 100, 200, or 400 μM H2O2 only for 6 h. Cell viability was estimated via
the trypan blue exclusion test. Untreated cells were used as the control. c Cells were treated with 0, 25, 50, or 100 μg/mL PPHs in the presence or
absence of 400 μM H2O2 for 6 h, and cell survival was assessed. d Cells were exposed to 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs
for 0, 2, 4, or 6 h, after which cell viability was assessed. *p < 0.05 versus cells treated with H2O2 alone (n = 3). PPHs porcine placenta hydrolysates
Lee et al. BMC Complementary and Alternative Medicine  (2016) 16:291 Page 4 of 10
apoptosis [31]. Thus, we evaluated the effect of PPHs on
caspase-12 activation. We found that caspase-12 activity
was increased significantly after H2O2 treatment, whereas
treatment with PPHs markedly reduced this H2O2-in-
duced increase in caspase-12 activity (Fig. 3c). Next, we
investigated caspase-3 activation. We found that H2O2 in-
creased caspase-3 activation, whereas this increase was
blocked by PPH treatment (Fig. 3d). Cells were exposed to
H2O2 in the absence or presence of PPHs for 2, 4, and 6 h,
after which the levels of apoptosis-related proteins were
analyzed. H2O2 significantly increased the levels of
caspase-12, caspase-3, and Bax in a time-dependent man-
ner; in contrast, treatment with PPHs markedly reduced
the protein levels of caspase-12, caspase-3, and Bax pro-
tein in MC3T3-E1 cells (Fig. 3e).
PPHs attenuate H2O2-mediated inhibition of ALP activity
To investigate the effect of PPHs on osteoblast differen-
tiation, we investigated the mRNA level and activity of
ALP in MC3T3-E1 cells. Treatment with 400 μM H2O2
a
b
Fig. 2 PPHs decrease the H2O2-induced ER stress response in MC3T3-E1 osteoblastic cells. a Cells were exposed to 400 μM H2O2 or 0.1 μM Tg
and 0, 25, 50, or 100 μg/mL PPHs for 6 h. Immunoblotting was performed using the indicated antibodies. b Cells were exposed to 400 μM H2O2
in the presence or absence of 100 μg/mL PPHs for 0, 2, 4, or 6 h. Immunoblotting was performed using the indicated antibodies. Blots are
representative of three independent experiments. *p < 0.05 versus cells treated with H2O2 alone (n = 3). PPHs porcine placenta hydrolysates,
Tg thapsigargin
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for 6 h significantly decreased the mRNA level of ALP.
However, treatment with PPHs markedly alleviated
H2O2-mediated downregulation of ALP. Similarly, treat-
ment for 6 h with 400 μM H2O2 markedly reduced ALP
activity in cells. However, treatment with 100 μg/mL
PPHs attenuated this effect of H2O2 (Fig. 4b).
PPHs attenuate H2O2-induced downregulation of
osteocalcin, Runx2, and osterix
To investigate the effects of PPHs on bone formation
proteins, we investigated the mRNA levels of osteocal-
cin, Runx2 [32], and osterix [33]. Treatment for 6 h with
400 μM H2O2 markedly decreased the mRNA level of
osteocalcin, whereas this change was markedly reversed
by PPHs. Similarly, H2O2 markedly downregulated the
mRNA levels of Runx2 and osterix (Fig. 5b and c). How-
ever, PPHs markedly attenuated this H2O2-mediated
downregulation of Runx2 and osterix.
PPHs affect ROS release, NADPH oxidase, and SOD
activity in MC3T3-E1 osteoblastic cells
To evaluate the antioxidant effects of PPHs, we investi-
gated the effect of PPHs on H2O2-mediated ROS pro-
duction. We found that treatment with 400 μM H2O2
for 2, 4, or 6 h markedly increased ROS production.
However, treatment with 100 μg/mL PPHs for 6 h mark-
edly attenuated this H2O2–mediated increase in intracel-
lular ROS (Fig. 6a). Next, we examined the effect of
PPHs on the activity of NADPH oxidase, an enzyme that





Fig. 3 PPHs protect against H2O2-induced apoptosis in MC3T3-E1 osteoblastic cells. a Apoptosis was detected by Hoechst dye staining and
quantified based on nuclear condensation or fragmentation (right). Representative pictures are shown from three independent experiments.
Images were taken at a magnification of 400×. Scale bar, 20 μm. b Cells were stained with FITC-conjugated Annexin V and PI, followed by flow
cytometric analysis. c Caspase-12 activity was analyzed in cells treated for 0, 12, 24, 36 or 48 h with 400 μM H2O2 in the presence or absence of
100 μg/mL PPHs. d Caspase-3 activity was measured in cells that were treated for 6 h with 400 μM H2O2 in the presence or absence of 100 μg/mL
PPHs. e Cells were treated for 0, 2, 4, or 6 h with 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs. Immunoblotting was performed using
the indicated antibodies. Representative blots are shown from three independent experiments. Bottom panel, quantitative immunoblot data (n = 4).
*p < 0.05 versus cells treated with H2O2 alone. PPHs porcine placenta hydrolysates
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H2O2-induced NADPH oxidase activity. These findings
suggest that PPHs have antioxidant effects on osteo-
blasts. Next, we investigated the effect of PPHs on SOD
activity. H2O2 treatment markedly inhibited SOD activ-
ity, whereas this effect was also alleviated by PPHs
(Fig. 6c).
Discussion
In this study, we found that PPHs protect MC3T3-E1
cells against H2O2-induced cell death and suppression of
differentiation. H2O2-induced oxidative stress is known
to lead to pathological ER stress. We found that PPHs,
presumably via their antioxidant effects, protected
MC3T3-E1 osteoblastic cells against H2O2-induced ER
stress and ROS production. Moreover, PPHs significantly
reversed H2O2-mediated downregulation of osteocalcin
and two related proteins involved in bone formation,
namely osterix and Runx2.
Reactive oxygen species (ROS) are generated by many
environmental agents and have been implicated in the
pathogenesis of various diseases, including osteoporosis
[34]. Reduced bone formation by osteoblasts may cause
osteoporosis to develop; moreover, the rate of osteoblast
apoptosis regulates bone formation [1, 2, 35, 36]. ER
stress has been implicated as an important factor in
apoptosis due to various causes, including osteoblast
apoptosis during the development of osteoporosis [11,
13, 14, 37]. The placenta has been studied for its poten-
tial to improve skin care, metabolic functions, and
strengthen immune function [23]. However, it has
remained unclear whether the placenta can protect oste-
oblasts from H2O2-induced ER stress and apoptosis.
Here we evaluated the effects of PPHs on H2O2-induced
ER stress and apoptosis in osteoblasts. ROS production
is known to decrease bone formation by osteoblastic
cells by suppressing the differentiation of osteoblast pro-
genitors and the calcification process [38]. Therefore,
decreased bone formation is strongly associated with
enhanced oxidative stress and significantly decreased
plasma levels of antioxidants in elderly persons with
osteoporosis [39, 40]. In this study, H2O2 induced cell
death, ER stress, and caspase-mediated apoptosis (Figs. 1,
2 and 3). However, PPH treatment prevented caspase
activation, thus reducing the amount of apoptosis in
response to ER stress. ER stress was recently reported to
be involved in the induction of apoptosis during osteo-
porosis [11, 12, 14, 37]. ER stress is activated by the
accumulation of unfolded proteins and alterations in cal-
cium homeostasis [6–8]. Recent studies have also shown
that ER stress-induced apoptosis of osteoblasts contrib-
utes to the development of osteoporosis [11–14, 37]. We
found that ER stress was decreased in MC3T3-E1 cells
(Fig. 2). However, treatment with PPHs increased osteo-
blast viability during periods of ER stress. Moreover,
PPHs inhibited osteoblast apoptosis in response to ER
stress. These results demonstrate that PPHs can protect
osteoblasts from ER stress-induced apoptosis.
Caspases are the most prominent mediators of apop-
tosis. However, it is not clear if activated caspase-12 or
caspase-3 plays an important role in H2O2-induced
apoptosis [41]. In this study, we found that PPHs
a
b
Fig. 4 PPHs alleviate H2O2-mediated inhibition of ALP activity in
MC3T3-E1 osteoblastic cells. a ALP mRNA levels in cells treated for
6 h with 400 μM H2O2 in the presence or absence of 100 μg/mL
PPHs were analyzed by RT-PCR. Representative bands are shown
from three independent experiments. Quantitative analysis of RNA
expression was also performed. b ALP activity levels were analyzed
in cells treated with 400 μM H2O2 in the presence or absence of
100 μg/mL PPHs (n = 3). *p < 0.05 versus cells treated with H2O2
alone. PPHs porcine placenta hydrolysates
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reversed the H2O2-induced activation of caspase-12 and
caspase-3 (Fig. 3). These results demonstrate that PPHs
can protect osteoblasts from caspase-mediated, H2O2-in-
duced apoptosis.
H2O2-induced apoptosis is primary mediated by ROS
production. We evaluated the protective effects of PPHs
and found that they decreased H2O2-induced ROS release
(Fig. 6). We also found that PPHs markedly inhibited
NADPH oxidase activity. NADPH oxidase is important
because it activates ROS-generating enzymes. PPHs also
alleviated H2O2-mediated inhibition of SOD activity. The
enhanced SOD activity observed upon treatment with
PPHs may result in the scavenging of excessive superox-
ides derived from oxidative stress, thus ameliorating
H2O2-induced cell death.
We also evaluated the effects of PPHs on osteoblastic
differentiation. ALP is a primary marker of osteoblast
differentiation. We found that H2O2 markedly downreg-
ulated ALP expression and that this effect was alleviated
by PPHs (Fig. 4). Our data thus indicate that PPHs
stimulate osteoblast differentiation. Furthermore, we also
analyzed the mRNA levels of Runx2, osterix, and osteo-
calcin. Osteocalcin is a major protein produced by osteo-
blasts during bone formation. Osteocalcin expression is
regulated by Runx2 and osterix levels [32, 42]. There-
fore, we assessed the expression of osterix and Runx2
after treatment with PPHs and/or H2O2 (Fig. 5). We found
that PPHs markedly reversed H2O2-mediated downregula-
tion of osterix and Runx2 expression. These findings sug-
gest that PPHs upregulate osteocalcin, osterix, and Runx2
expression.
It was beyond the scope of the present study to iden-
tify the active component(s) in PPHs. However, recent




Fig. 5 PPHs reverse the effects of H2O2 on the mRNA expression of osteocalcin, Runx2, and osterix in MC3T3-E1 osteoblastic cells. Osteocalcin (a),
Runx2 (b), and Osterix (c) expression levels in cells treated for 6 h with 400 μM H2O2 in the presence or absence of 100 μg/mL PPHs were analyzed by
RT-PCR. Representative bands are shown from three independent experiments. Quantitative analysis of RNA expression was also performed. *p < 0.05
versus cells treated with H2O2 alone. PPHs porcine placenta hydrolysates
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may play an important role in bone development, growth,
and modeling [43]. Moreover, arginine is thought to allevi-
ate metabolic disturbances in calcium absorption, growth,
dentition, and decalcification [44]. PPHs are known to
contain high levels of arginine and other essential amino
acids. Thus, our findings provide evidence that PPHs may
have potential therapeutic value for treating bone metab-
olism disturbances in osteoblasts.
Conclusions
Our findings suggest that PPHs, presumably via their anti-
oxidant effects, protect MC3T3-E1 osteoblasts against
H2O2-induced ER stress by suppressing ROS production.
Furthermore, PPHs regulate oxidative stress-induced
osteoporosis. Cumulatively, our findings suggest that
PPHs may have potential therapeutic value for treating
bone formation disturbances.
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Fig. 6 PPHs regulate ROS release, NADPH oxidase, and SOD activity
in MC3T3-E1 osteoblastic cells. a ROS production was analyzed in
cells treated for 6 h with 400 μM H2O2 in the presence or absence
of 100 μg/mL PPHs by the DCF-DA assay. NADPH oxidase (b) and
SOD activities (c) were assessed in cells treated for 6 h with 400 μM
H2O2 in the presence or absence of 100 μg/mL PPHs. Representative
bands are shown from three independent experiments. Quantitative
analysis of RNA expression was also performed. *p < 0.05 versus cells
treated with H2O2 alone. PPHs, porcine placenta hydrolysates
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